MBRX — Moleculin Biotech Cashflow Statement
0.000.00%
Last trade - 00:00
- $10.36m
- -$13.19m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13.2 | -17.4 | -15.9 | -29 | -29.8 |
Depreciation | |||||
Non-Cash Items | -2.05 | -0.575 | -4.26 | 1.03 | 3.92 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.14 | -0.041 | 1.04 | 0.224 | 1.62 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -17.2 | -17.8 | -19 | -27.6 | -24.1 |
Capital Expenditures | -0.052 | -0.376 | -0.019 | -0.067 | -0.124 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.001 | 0.002 | 0 | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.051 | -0.374 | -0.019 | -0.067 | -0.124 |
Financing Cash Flow Items | — | -0.017 | -0.023 | -0.023 | 0.485 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 20.9 | 22.5 | 74.7 | -0.023 | 4.65 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.6 | 4.44 | 55.7 | -27.8 | -19.6 |